Variations in genome’s 'dark matter' region can make patients susceptible to inflammatory diseases

Variations in genome’s 'dark matter' region can make patients susceptible to inflammatory diseases

Variations in genome’s 'dark matter' region can make patients susceptible to inflammatory diseases

A study led by researchers at the Babraham Institute in collaboration with the Wellcome Sanger Institute has uncovered how variations in a non-protein coding 'dark matter' region of the genome could make patients susceptible to complex autoimmune and allergic diseases such as inflammatory bowel disease.